Approved Date Route External Links
2016-08-12 Intravenous Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Daptomycin For Injection Is Indicated For The Treatment Of The Infections Listed Below. Daptomycin For Injection Is A Lipopeptide Antibacterial Indicated For The Treatment Of: Complicated Skin And Skin Structure Infections (csssi) (1.1) Staphylococcus Aureus Bloodstream Infections (bacteremia), Including Those With Right-Sided Infective Endocarditis. (1.2) Daptomycin For Injection Is Not Indicated For The Treatment Of Pneumonia. (1.3) To Reduce The Development Of Drug-Resistant Bacteria And Maintain The Effectiveness Of Daptomycin For Injection And Other Antibacterial Drugs, Daptomycin For Injection Should Be Used To Treat Infections That Are Proven Or Strongly Suspected To Be Caused By Bacteria. 1.1 Complicated Skin And Skin Structure Infections Complicated Skin And Skin Structure Infections (csssi) Caused By Susceptible Isolates Of The Following Gram-Positive Bacteria: Staphylococcus Aureus (including Methicillin-Resistant Isolates), Streptococcus Pyogenes, Streptococcus Agalactiae, Streptococcus Dysgalactiae Subsp. Equisimilis, And Enterococcus Faecalis (vancomycin-Susceptible Isolates Only). 1.2 Staphylococcus Aureus Bloodstream Infections (bacteremia), Including Those With Right-Sided Infective Endocarditis, Caused By Methicillin-Susceptible And Methicillin-Resistant Isolates Staphylococcus Aureus Bloodstream Infections (bacteremia), Including Those With Right-Sided Infective Endocarditis, Caused By Methicillin-Susceptible And Methicillin-Resistant Isolates. 1.3 Limitations Of Use Daptomycin For Injection Is Not Indicated For The Treatment Of Pneumonia. Daptomycin For Injection Is Not Indicated For The Treatment Of Left-Sided Infective Endocarditis Due To S. Aureus. The Clinical Trial Of Daptomycin For Injection In Patients With S. Aureus Bloodstream Infections Included Limited Data From Patients With Left-Sided Infective Endocarditis; Outcomes In These Patients Were Poor [see Clinical Trials 14.2]. Daptomycin For Injection Has Not Been Studied In Patients With Prosthetic Valve Endocarditis. 1.4 Usage Appropriate Specimens For Microbiological Examination Should Be Obtained In Order To Isolate And Identify The Causative Pathogens And To Determine Their Susceptibility To Daptomycin. To Reduce The Development Of Drug-Resistant Bacteria And Maintain The Effectiveness Of Daptomycin For Injection And Other Antibacterial Drugs, Daptomycin For Injection Should Be Used Only To Treat Infections That Are Proven Or Strongly Suspected To Be Caused By Susceptible Bacteria. When Culture And Susceptibility Information Is Available, It Should Be Considered In Selecting Or Modifying Antibacterial Therapy. In The Absence Of Such Data, Local Epidemiology And Susceptibility Patterns May Contribute To The Empiric Selection Of Therapy. Empiric Therapy May Be Initiated While Awaiting Test Results.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Daptomycin

Comments